ライフサイエンスコーパス: topical agent

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 d to facilitate hemostasis by application of topical agents.

2 mucus discharge, urgency, and treatment with topical agents.

3 d incident rate compared with treatment with topical agents.

4 e efficaciously reduced by administration of topical agents.

5 racameral antibiotic was more effective than topical agent alone (OR, 0.58; CI, 0.38-0.91).

6 ents with severe psoriasis were treated with topical agents alone.

7 y of imiquimod, 26, which was developed as a topical agent and has been approved for the treatment of

8 Topical agents and botulinum toxin A are recommended for

9 lving genetically modified mice treated with topical agents and human dermatological conditions, such

10 of mechanical fragility, toxicity of various topical agents, and the use of emollients.

11 c approach to therapy should be used wherein topical agents are altered every 6-8 months and technolo

12 n protection) followed by stepwise trials of topical agents (e.g., capsaicin), antiepileptic drugs (e

13 and cats which was directly compared to the topical agents fipronil and imidacloprid, with favorable

14 compounds have the potential to be effective topical agents for treating respiratory inflammatory dis

15 The two topical agents for treatment of BV have differing microb

16 roved as well, with the development of newer topical agents for vitiligo, including topical calcineur

17 Although these topical agents have recently been introduced in commerci

18 rt-term protocols for testing the utility of topical agents in the repair of photoaged skin.

19 l allow physicians to understand the role of topical agents in the treatment of intractable pain synd

20 e findings of the present study suggest that topical agents may effectively reduce N. gonorrhoeae inf

21 versely steroid-sparing approaches including topical agents such as beclomethasone or sirolimus as a

22 Treatment of atopic dermatitis with topical agents such as tacrolimus ointment and phosphodi

23 Topical agents, such as microbicides, that can protect a

24 or nonmelanoma skin cancer (NMSC), including topical agents, surgery, or definitive or adjuvant radia

25 an unmet dermatological need for innovative topical agents that achieve better longterm outcomes wit

26 ndispensable for the testing of vaccines and topical agents that are aimed toward the prevention of h

27 Moreover, topical agents that lower IOP in normotensive mice also

28 owerful and feasible strategy to develop new topical agents that suppress AR.

29 is currently the most frequently prescribed topical agent, though the use of ELA-max, another lidoca

30 virus, they show promise for development as topical agents to avert sexually transmitted diseases.

31 Therapy includes topical agents to improve moisture and decrease inflamma

32 that retrocyclin-like agents might be useful topical agents to prevent sexually acquired HIV-1 infect

33 ated molecules could serve as prototypes for topical agents to prevent sexually transmitted chlamydia

34 e effects, can potentially be developed into topical agents to prevent skin photocarcinogenesis, part

35 sm used in rinse-off formulations to deliver topical agents to the skin and hair; this process produc

36 Treatments currently available are: topical agents used predominantly for mild disease and f

37 Their unique appeal as nonsteroidal topical agents with good safety profiles has led to thei

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。